Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Gilead Sciences
University of Washington
Acerta Pharma BV
Roswell Park Cancer Institute
City of Hope Medical Center
University of Rochester
Stanford University
Mayo Clinic
University of Nebraska
University of Nebraska
Abramson Cancer Center at Penn Medicine
Brown University
Karyopharm Therapeutics Inc
Mayo Clinic
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Cancer Research UK
ADC Therapeutics S.A.
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Gilead Sciences
Pharmacyclics LLC.
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Arizona
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Gilead Sciences
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Gilead Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences